BAJAJ HEALTHCARE
|
The Current P/E Ratio of BAJAJ HEALTHCARE is 20.25.
| Share Price | ₹314.4 | Apr 07,2026 |
| Market Cap | ₹1,059.4 Cr | |
| Earnings-TTM | ₹52.3 Cr | TTM-Standalone Results |
| Price/Earnings | 20.25x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of BAJAJ HEALTHCARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,059.4 Cr] as on Apr 07,2026
(/) Earnings [ ₹52.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 20.25x ]
Thus, for BAJAJ HEALTHCARE , the investors are currently willing to pay 20.25 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BAJAJ HEALTHCARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BAJAJ HEALTHCARE over the last five years.
Historical PE (Price/Earnings) ratio chart of BAJAJ HEALTHCARE
PE Ratio Performance Analysis for BAJAJ HEALTHCARE
- BAJAJ HEALTHCARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 15.95x.
- BAJAJ HEALTHCARE 's operated at median p/e ratio of 13.16x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAJAJ HEALTHCARE 's p/e ratio peaked in Mar2025 at 49.42x.
- BAJAJ HEALTHCARE 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does BAJAJ HEALTHCARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| BAJAJ HEALTHCARE | 52.32 | 20.25 | 1,059.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 37.48 | 412,326.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 62.64 | 155,282.0 |
| CIPLA LTD | 4,544.70 | 21.37 | 97,115.7 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 60.32 | 137,043.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 18.13 | 99,854.2 |
| MANKIND PHARMA LTD | 1,796.65 | 46.88 | 84,231.4 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 17.82 | 87,909.6 |
| LUPIN LTD | 4,669.18 | 22.49 | 104,996.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 21.98 | 77,223.4 |
| ABBOTT INDIA LTD | 1,524.13 | 35.78 | 54,530.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BAJAJ HEALTHCARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.82x |
| Max industry PE | 62.64x |
| Median industry PE | 22.49x |
| Average industry PE | 33.19x |
You may also like the below Video Courses